Over-The-Counter Tests Market Size, Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2024 – 2032
Report ID: GMI3575
Download Free PDF
Authors:
Monali Tayade,
Over-The-Counter Tests Market Size
Over-The-Counter Tests Market size will register significant growth between 2024 and 2032, propelled by rising government investments and initiatives. With governments worldwide prioritizing public health and encouraging preventive healthcare measures, funding for research, development, and distribution of over-the-counter tests has surged.
For instance, in September 2023, The U.S. Department of Health and Human Services (HHS), under the Administration for Strategic Preparedness and Response, unveiled a $600 million investment across 12 domestic COVID-19 test manufacturers. Additionally, COVIDTests.gov was being relaunched to provide free COVID-19 tests to households nationwide. These significant investments in domestic manufacturing enhanced readiness for COVID-19 and other potential pandemics, bolstering the nation's testing capabilities and procuring around 200 million new over-the-counter COVID-19 tests for future federal government utilization.
Initiatives aimed at expanding access to affordable and convenient diagnostic options further drive market progression. As policymakers recognize the importance of early detection and self-monitoring in managing various health conditions, the demand for over-the-counter tests continues to rise, shaping the landscape of modern healthcare.
The over-the-counter tests market experiences heightened demand as regulatory bodies approve more home diagnostic kits and tests. With advancements in technology and increased emphasis on consumer empowerment in healthcare, there is a growing trend towards self-monitoring and early detection of health conditions. As home diagnostic kits gain approvals for various ailments, including infectious diseases, chronic conditions, and genetic predispositions, consumers seek convenient and accessible options for testing.
This rising approval of home diagnostic kits drives market demand, providing individuals with greater control over their health. For instance, in November 2023, the Flowflex COVID-19 Antigen Home Test from ACON Laboratories originally cleared for emergency use in 2021, emerged as the second home COVID-19 test to undergo a conventional FDA premarket assessment, sanctioned for individuals under 18, marking a pioneering feat in the process. Regulatory clearance was secured from the U.S. Food and Drug Administration for this over-the-counter antigen test for COVID-19 for the first time.
The over-the-counter tests market faces limitations despite its growth trajectory. One notable restraint is the potential for inaccurate results or misinterpretation by consumers, leading to false reassurance or unnecessary anxiety. Additionally, regulatory requirements for approval and quality assurance pose challenges for manufacturers, potentially delaying product launches. Furthermore, competition from alternative testing methods and the need for continuous innovation to meet evolving consumer demands further restrict market expansion. These factors collectively contribute to restraints hindering the widespread adoption of over-the-counter tests.
Over-The-Counter Tests Market Trends
The industry experiences dynamic trends influenced by approvals and clearances from government organizations for various drugs. As regulatory bodies greenlight more medications for over-the-counter (OTC) use, the market witnesses a surge in demand for corresponding diagnostic tests. With consumers increasingly seeking self-management options for various health conditions, the availability of OTC tests aligns with this trend. Government approvals not only validate the safety and efficacy of these tests but also catalyze innovation and competition within the market, driving its gains and evolution.
To cite an instance, in October 2023, the Food and Drug Administration granted marketing clearance for the initial over-the-counter test designed to detect fentanyl in urine. This five-minute test delivers preliminary results, and it comes with a pre-addressed mailing box for sending samples to the laboratory of the manufacturer for further confirmation testing, utilizing an alternative method involving chemical analysis. The agency hastened the review process for the Alltest Fentanyl Urine Test Cassette, completing clearance within just 16 days of receiving the submission.
Over-The-Counter Tests Market Analysis
The online pharmacies segment might generate a continual inflow of revenue through 2032. Since the outbreak of the pandemic, the number of online customers has been growing across these platforms. As more people are inclined toward the use of smartphones and other mobile devices for ordering medicines and other pharma products, offline medical stores are migrating to digital platforms. Online platforms offer a wide range of over-the-counter tests, providing easy access to consumers seeking convenient and discreet ways to monitor their health. This trend toward online purchasing of diagnostic tests underscores the growing role of digital health platforms in expanding access to essential healthcare products.
North America over-the-counter tests market share is poised to rise during the forecast timeline, supported by the favorable government policies and funding activities. In December 2021, U.S. President Joe Biden announced his plan to make at-home COVID-19 tests extensively available to the regional population. These kits will be made available free of charge in anticipation of the omicron variant surge. Alaskan citizens can also pick up free COVID testing kits from their nearest community hospitals & health centers.
The growing footprint of newer strains of diseases, including dengue and malaria, across the region is influencing Latin America industry outlook. With a significant rise in the number of various disorders and diseases, the dependence on these testing strips has grown considerably across small clinics in the last couple of years. In December 2020, the government of New Mexico announced the launch of free self-administered COVID-19 saliva tests. It signed a contract with Vault Medical Services which will provide the kit and test results within 48 hours. Nearly 9,300 New Mexicans availed of these kits, boosting the regional outlook.
Over-The-Counter Tests Market Share
Major companies operating in the over-the-counter tests industry competitive landscape include:
Over-The-Counter Tests Industry News
In July 2023, The Food and Drug Administration approved the first birth control pill to be sold without a prescription in the United States, a move expected to greatly enhance contraception accessibility. Known as Opill, this medication would stand as the most potent over-the-counter birth control method, surpassing condoms, spermicides, and other nonprescription options in preventing pregnancy. Reproductive health experts highlighted its potential significance for young women, teenagers, and individuals facing challenges in accessing prescriptions due to factors such as time, cost, or logistical barriers associated with doctor visits.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →